Product Information
ROPINIROLE HCL ER 8 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $1.0184 per EA under NDC 43547055709. Its NADAC has been published 204 times since Sep 28, 2022.
FDA first approved this application on May 11, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
8 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547055709
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLEApproval Type
Generic (ANDA)
FDA Application
ANDA204413FDA Approved
5/11/2022
TE Code
AB
On Market Since
3/22/2022
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 8 MG TABLET has been published 204 times since Sep 28, 2022, and over the history we have for it it has risen 21.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0184 per EA |
|---|---|
| All-time high | $1.8018 (Dec 11, 2024) |
| All-time low | $0.7082 (Nov 23, 2022) |
| 52-week high | $1.5166 |
| 52-week low | $0.7180 |
| Median price | $1.3054 |
| Average price | $1.2834 |
| Largest weekly change | +104.0% (Dec 21, 2022) |
| Weeks tracked | 204 |
| Tracking since | Sep 28, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 8 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 8 MG TABLET, manufactured by Solco Healthcare US LLC, is $1.0184 per EA (NDC 43547055709), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL ER 8 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has risen 21.2%. It has been tracked across 204 weekly CMS publications since Sep 28, 2022.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 8 MG TABLET?
Since Sep 28, 2022, the NADAC for ROPINIROLE HCL ER 8 MG TABLET has ranged from a low of $0.7082 (Nov 23, 2022) to a high of $1.8018 (Dec 11, 2024), with a median of $1.3054 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 8 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL ER 8 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROPINIROLE HCL ER 8 MG TABLET?
ROPINIROLE HCL ER 8 MG TABLET (NDC 43547055709) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.